APA (7th ed.) Citation

Kinzler, E. R., Pantaleon, C., & Aigner, S. (2018). Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects. Clinical therapeutics, 40(8), 1357-1365. https://doi.org/10.1016/j.clinthera.2018.06.010

Chicago Style (17th ed.) Citation

Kinzler, Eric R., Carmela Pantaleon, and Stefan Aigner. "Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects." Clinical Therapeutics 40, no. 8 (2018): 1357-1365. https://doi.org/10.1016/j.clinthera.2018.06.010.

MLA (9th ed.) Citation

Kinzler, Eric R., et al. "Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects." Clinical Therapeutics, vol. 40, no. 8, 2018, pp. 1357-1365, https://doi.org/10.1016/j.clinthera.2018.06.010.